ANDHealth+ is focused on assisting Australian digital and connected health SMEs to meet key investor, partner and customer requirements around clinical and commercial validation. The program is unique in that it requires no equity consideration and that each cohort company’s advisory panel and project is tailored specifically to that company.
ANDHealth+ staff and advisors meet strict criteria – they must demonstrate hands-on experience in:
ANDHealth+ is a novel program, bespoke to each company and not curriculum based, and requires significant in-kind from industry leaders. Therefore, we have a number of expectations regarding the conduct of cohort companies, outlined below. In applying for ANDHealth+ you indicate that you accept these expectations.
ATTITUDE Cohort companies shall approach the ANDHealth+ program, panel meetings and industry feedback with an open and receptive attitude. All participants are expected to act with professionalism, integrity, and respect in every interaction with ANDHealth staff and advisors, ensuring a supportive and inclusive environment for collaboration and success. Our Industry Panellists are providing their time in-kind and we ask that cohort companies respect this, and the time and intellectual effort contributed by the panel.
PROJECT The cohort company will work with their panel to refine their tailored project plans for Stage 1 and Stage 2 and once the project plans are agreed, the cohort company will fulfil all agreed company side contributions and will meet deadlines related to their project input.
PANEL MEETINGS There are regular panel meetings, meetings with third party providers, meetings with in-kind ANDHealth partners and members and ad hoc meetings which you are expected to attend. It is also expected that you will undertake appropriate preparation prior to these meetings. Participants will remain mindful and respectful of ANDHealth’s networks by working through the team on communications, and are not permitted to contact IAP, ISP and IIC members or other network partners outside of approved channels. Soliciting business, investment, or any form of engagement from IAP, ISP, or IIC members, or other network partners, without prior written approval from ANDHealth is strictly prohibited.
REPORTING The cohort company agrees to report on a quarterly basis requested metrics (for example new patients served, new regulatory approvals and new revenue) associated with company outcomes. These are to be reported to ANDHealth, for ANDHealth’s use and disclosure to the MRFF funding agency under obligatory reporting requirements. Cohort companies will be required to report back to ANDHealth across agreed metrics for three years post completion of the program.
BOARD MEETINGS ANDHealth+ believe that there is value in meeting with each cohort company’s Board of Directors at the conclusion of the program and expects cooperation from the cohort company to facilitate this.
ADDITIONAL ACCELERATOR PROGRAMS While ANDHealth supports and works in partnership with many complementary accelerator programs, the ANDHealth+ program requires significant effort. As such cohort companies are expected to notify ANDHealth of any plans to apply to additional programs and may be asked to confirm in writing that participation in subsequent programs will not limit or slow the company’s contribution to the ANDHealth+ program.
CAPITAL RAISING If a company is in the process of raising capital during the application and selection process, ANDHealth will assist as practicable. As a focus of the ANDHealth+ program is investment and commercialisation readiness, ensuring our cohort companies are as prepared as possible for the capital raising process, and providing insights into how to successfully navigate this, are core to the program. Following commencement of the program, cohort companies will be expected to work with ANDHealth and relevant advisors in relation to any capital raising. Cohort companies will be expected to discuss activities such as investor roadshows / pitches, appointment of independent corporate advisors, and, to a lesser extent, applications for non-dilutive funding, with ANDHealth prior to commencing any face-to-face investor meetings or executing any mandates.
EVENTS PARTICIPATION ANDHealth run a series of events and workshops across Australia and lead participation in international conferences. Cohort companies are expected to attend ANDHealth conferences where at all possible, and to consider participating in international delegations in key markets.
You may, at ANDHealth’s discretion, be invited to participate at our and our partners events such as international investor days, local and international conferences, government showcases and other activities. As part of this participation, it is expected that you will work with our Communications team and fairly acknowledge the impact and opportunities provided by ANDHealth+.
INVESTOR & CUSTOMER DEAL FLOW DAY At the end of each Stage of the program, ANDHealth will facilitate a day of investor and customer pitching for the cohort companies. Investor meetings will be held with investors who ANDHealth knows have an interest in and a mandate allowing investment into the digital health space. Cohort companies will be supported by ANDHealth’s team and members prior to and during these investment and enterprise customer meetings.
MEDIA ANDHealth seeks to promote the achievements of all of its cohort companies by incorporating cohort company news into our ongoing communications and social media. In addition, we have an expectation that cohort companies will provide positive commentary on ANDHealth and ANDHealth+ where relevant. Key ANDHealth messages will be provided to all cohort companies and media training and support can also be facilitated. All cohort company media releases referencing ANDHealth should be approved by ANDHealth communications and/ or executive staff. Where possible cohort companies should also provide written media mentioning ANDHealth for review by us before publication.
You may be invited to participate in media opportunities as part of the program. When you are invited to participate in ANDHealth media we will expect you to work with our Communications team and to adhere to agreed messaging and fairly acknowledge the impact and opportunities provided by ANDHealth.
